The global Brucella Abortus Vaccine market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Brucella Abortus Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Brucella Abortus Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Brucella Abortus Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others

Segment by Application
Cattles
Sheep
Pigs
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health